日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neoadjuvant BO-112 and hypofractionated radiation therapy with or without nivolumab in soft tissue sarcoma: preclinical and phase 1 results

新辅助 BO-112 联合或不联合纳武利尤单抗的低分割放射治疗在软组织肉瘤中的应用:临床前和 I 期研究结果

Deng, Jie; Pal, Aastha; Testa, Stefano; Xu, Jingyu W; Tran, Linh M; Graham, Danielle S; Hargil, Aviv; Subramanian, Ajay; Campbell, Katie M; Limsuwannarot, Sam; Chumpitaz Lavalle, Álvaro; Chin, Scott C; Kremer, Sarah; Tariveranmoshabad, Mito; Ewongwo, Agnes; Silvia, Sk Nadia Rahman; Ogana, Heather; Nemat-Gorgani, Neda; Dubinett, Steven M; Jaycox, Jillian R; Felix, Carol; Schaue, Dörthe; Nelson, Scott D; Levine, Benjamin; Motamedi, Kambiz; Ghazikhanian, Varand; Chmielowski, Bartosz; Reddy, Vishruth; Singh, Arun S; Trnkova, Zuzana Jirakova; Good, Zinaida; Quintero, Marisol; Crompton, Joseph G; Bernthal, Nicholas; Eilber, Fritz C; Moding, Everett J; Kalbasi, Anusha

SCAN-ACT: adoptive T cell therapy target discovery through single-cell transcriptomics.

SCAN-ACT:通过单细胞转录组学发现过继性T细胞疗法靶点

Testa Stefano, Pal Aastha, Subramanian Ajay, Varma Sushama, Tang Jack Pengfei, Graham Danielle, Arfan Sara, Pan Minggui, Bui Nam Q, Ganjoo Kristen N, Dry Sarah, Huang Paul, van de Rijn Matt, Jiang Wei, Kalbasi Anusha, Moding Everett J

IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapy

IL-9 作为一种天然正交细胞因子,具有最佳的 JAK/STAT 信号通路活性,可用于工程化 T 细胞治疗。

Jiang, Hua; Limsuwannarot, Sam; Kulhanek, Kayla R; Pal, Aastha; Rysavy, Lea W; Su, Leon; Labiad, Ossama; Testa, Stefano; Ogana, Heather; Waghray, Deepa; Tao, Pingdong; Jude, Kevin M; Seet, Christopher S; Crooks, Gay M; Moding, Everett J; Garcia, K Christopher; Kalbasi, Anusha